HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma
European Archives of Oto-Rhino-Laryngology · 2026-06 · 283 (6) · 3963-3977
DOI: 10.1007/s00405-026-10128-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 28.03.2026. Verfasst von Huo-Cong He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Radiation Tolerance, Nasopharyngeal Carcinoma, Heat-Shock Proteins. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of China, Joint Funds for the Innovation of Science and Technology, Fujian province, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to determine HSPA5 expression in NPC, evaluate its prognostic significance in patients receiving radiotherapy, and validate these findings in vitro. METHODS: In 107 NPC patients, the association between HSPA5 expression and clinicopathological characteristics was assessed using the chi-square test. All tumor specimens were collected before radiotherapy and were pathologically confirmed as poorly differentiated or undifferentiated without distant metastasis. All patients subsequently underwent radiotherapy and were followed for survival outcomes. In vitro, an HSPA5-knockout C666-1R cell line (C666-1R KO) was generated using CRISPR/Cas9, whereas HSPA5 overexpression in radiosensitive C666-1 cells (C666-1 OE) was established by transfection with the pcDNA3.1(+)-HSPA5 plasmid. The effects of HSPA5 expression on post-irradiation clonogenic survival, migration, and invasion were evaluated. RESULTS: In NPC, HSPA5 expression was associated with gender, recurrence, distant metastasis, disease progression and radiosensitivity, but not with age, Histologic pattern, clinical stage, T stage, or N stage. High HSPA5 expression was detected in 47 NPC specimens. Kaplan–Meier analysis showed that, compared with the low-expression group, patients with high HSPA5 expression had significantly shorter distant metastasis-free survival (DMFS), progression-free survival (PFS) and locoregional recurrence-free survival (LRRFS). Although not statistically significant, overall survival (OS) also tended to be worse in the high-expression group, with clear separation of survival curves. In vitro experiments demonstrated that loss of HSPA5 sensitized C666-1R cells to irradiation, whereas forced HSPA5 expression conferred relative radioresistance in C666-1 cells. Following irradiation, HSPA5 knockout markedly reduced the migration and invasion of C666-1R cells, while HSPA5 overexpression enhanced these abilities in C666-1 cells. CONCLUSION: HSPA5 overexpression correlates with poorer prognosis in NPC and acts as a key driver of post-irradiation survival and dissemination. HSPA5 is a promising biomarker for predicting radiotherapy response and clinical outcomes, and its therapeutic inhibition may help overcome radioresistance and metastasis in NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- College of Chemistry, Fuzhou University, Fuzhou, China.
- School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
- NHC Key Laboratory of Cancer Metabolism (Fujian Cancer Hospital), Fuzhou, China.
- Department of Integrative Medicine, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, China. panjr@fzu.edu.cn.
Förderung
- Natural Science Foundation of China
- Joint Funds for the Innovation of Science and Technology, Fujian province
- Natural Science Foundation of Fujian Province
Zitieren
APA
He, H. C., Ge, N., Huang, Z. R., Wang, S. L., Lin, X. D., & Pan, J. R. (2026). HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology, 283(6), 3963-3977. https://doi.org/10.1007/s00405-026-10128-9
Vancouver
He HC, Ge N, Huang ZR, Wang SL, Lin XD, Pan JR. HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 2026;283(6):3963-3977. doi:10.1007/s00405-026-10128-9
BibTeX
@article{He2026,
author = {He, Huo-Cong and Ge, Na and Huang, Zheng-Rong and Wang, Shao-Li and Lin, Xian-Dong and Pan, Jian-Ru},
title = {HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
volume = {283},
number = {6},
pages = {3963--3977},
doi = {10.1007/s00405-026-10128-9}
}
EUVIMED